Month: May 2024

Surgery Partners, Inc. Announces First Quarter 2024 Results

Written by Customer Service on May 7, 2024. Posted in Earnings Releases And Operating Results.

Raises Full Year 2024 Guidance BRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024.Revenues increased 7.7% to $717.4 million compared to the prior year periodSame-facility revenues increased 10.2%Net loss attributable to Surgery Partners, Inc. was $12.4 millionAdjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year periodAdjusted EBITDA margin improved year-over-year to 13.6% Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDAWayne DeVeydt, Executive Chairman of the Board of Surgery Partners, noted, “We...

Falcon Oil & Gas Ltd – TSX Venture Exchange Conditional Approval & Additional Subscription

Written by Customer Service on May 7, 2024. Posted in Public Companies.

Falcon Oil & Gas Ltd(“Falcon”, the “Company” or the “Group”) TSX Venture Exchange Conditional Approval & Additional Subscription 7 May 2024 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG), the international oil and gas company engaged in the exploration and development of unconventional oil and gas assets, is pleased to confirm that it has received TSX Venture Exchange conditional approval for the second tranche of the Subscription by Sheffield Holdings LP, as previously announced on 22 April 2024. Accordingly, the Company has today issued a further 6,638,597 New Common Shares to Sheffield Holdings LP at an Issue Price of £0.06p per share, taking the aggregate interests of Sheffield Holdings LP to 116,386,398 Common Shares, representing 10.49 per cent of the enlarged issued share capital. Application for Admission It...

MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update

Written by Customer Service on May 7, 2024. Posted in Public Companies.

MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business UpdateAnnounced positive feedback from both FDA and EMA on the regulatory path for the Phase 3 program of the Nanobody® sonelokimab in hidradenitis suppurativa (HS) and outlined the development plan with topline results anticipated in mid-2025 Reported significant improvements observed across all key outcomes with sonelokimab over 24 weeks in the ARGO Phase 2 trial in active psoriatic arthritis (PsA) including unprecedented multi-domain responses across joints, skin and other domains, supporting potential best-in-class profile of sonelokimab Announced the imminent commencement of four additional clinical trials of sonelokimab across dermatology, and rheumatology, including innovative trials in palmo-plantar pustulosis (PPP), juvenile HS and...

Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024

Written by Customer Service on May 7, 2024. Posted in Public Companies.

PLANO, Texas, May 07, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society (HRS) educational event and exhibition in Boston from May 16 – 19, 2024. HRS attendees are invited to visit Integer at booth #753 to learn more about the company’s comprehensive end-to-end solutions, designed to help customers accelerate time to market, strengthen innovation, simplify supply chain and confidently scale production across a globally competitive network of locations. Some examples include market-leading battery technology, finished leads and implantable pulse generators (IPG) for cardiac applications. Integer is a leading manufacturer...

Dayforce Releases Dayforce Partner Exchange

Written by Customer Service on May 7, 2024. Posted in Public Companies.

An open and connected marketplace to help Dayforce customers accelerate HR innovation and unlock more value MINNEAPOLIS and TORONTO, May 07, 2024 (GLOBE NEWSWIRE) — Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the availability of Dayforce Partner Exchange, a curated ecosystem of software and services partners that implement and extend Dayforce solutions. Dayforce customers are now able to access fully vetted system integrators and technology providers within the Dayforce platform, helping to accelerate business goals and drive value. “Today’s organizations are facing a complexity crisis driven by a changing labor market, regulatory intricacies, and the ever-pressing need to meet market demand,” said Josh Valdez, Senior Vice President, Product,...

BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Written by Customer Service on May 7, 2024. Posted in Public Companies.

Conference Call on Tuesday, May 14th, at 4:30 pm ET POMPANO BEACH, Fla., May 07, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading biotechnology company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, announced today that it plans to release its first quarter 2024 financial results post-market on Tuesday, May 14, 2024. BioStem will host a conference call and webcast at 4:30 pm ET on Tuesday, May 14, 2024. The call will include a discussion of first quarter 2024 financial results and a corporate update. The live call can be accessed by dialing USA / International Toll +1 .646.968.2525USA – Toll-Free +1.888.596.4144 The live and archived webcast of the call will also be available on the BioStem Technologies website under the Investors...

Speedemissions, Inc. Announces Student Winners of its Inaugural $100,000 “Project Planet Young Entrepreneur” Competition

Written by Customer Service on May 7, 2024. Posted in Public Companies.

ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) — Speedemissions, Inc. (OTC Markets Expert Market: SPMI) (the “Company”), a retail brand vehicle testing and safety inspections company that has helped reduce auto emissions for over 20 years, with nineteen operating stores in Atlanta and St. Louis markets, is pleased to announce the winners of its Project Planet Young Entrepreneur competition. On May 2nd, a committee comprised of business and environmental professionals selected two standout student contributors for recognition: Danielle Hanson proposed an innovative storage container utilizing a solar-powered filtration system for processing rain or ground-sourced water. Shuham Madhavi submitted a bio-brick technology converting CO2 into coral-restoring nutrients to help regenerate reef ecosystems and combat climate change. Speedemissions...

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

Written by Customer Service on May 7, 2024. Posted in Earnings Releases And Operating Results.

MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the first quarter ended March 31, 2024. Highlights:Revenue of $1.9 million, a 2% increase over the prior-year period. Consumables sales, representing 82% of total revenue, grew 11% year-over-year. Pediatric revenue growth of 40% year over year led by a 54% increase in consumable sales. Gross margin of 64.1%, compared to 58.4% in the prior year period. Received FDA clearance for an additional dual lumen extended length catheter. Launched Aquadex® ultrafiltration therapy for heart failure patients as a part of Nuwellis’ pivotal REVERSE-HF clinical study at Henry Ford Health. Company anticipates significant expense reductions...

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Written by Customer Service on May 7, 2024. Posted in Earnings Releases And Operating Results.

IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the first quarter ended March 31, 2024. First Quarter and Recent HighlightsIn December 2023, the pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoints The Company implemented cost savings initiatives, including suspension of all mavodelpar development activities and a total workforce reduction of approximately 90% The Company retained an independent financial advisor to initiate a formal process to evaluate potential strategic alternativesFinancial...

First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results

Written by Customer Service on May 7, 2024. Posted in Earnings Releases And Operating Results.

Total revenues increased 14.7%; same-restaurant sales growth of 0.5%*Income from operations margin of 5.1% and restaurant level operating profit margin of 20.8%Net income of $7.2 million and Adjusted EBITDA of $28.6 million9 system-wide restaurants opened across 8 states BRADENTON, Fla., May 07, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today reported financial results for the thirteen weeks ended March 31, 2024 (“Q1 2024”). “First Watch posted another solid quarter with positive same restaurant sales*, traffic trends that improved sequentially through the quarter and year-over-year adjusted EBITDA growth,” said Chris Tomasso, First Watch CEO and President. “We continue to focus on delivering...

Month: May 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals